ISLB 2022 | Potential of machine learning in liquid biopsy

Adam Widman, MD, Memorial Sloan Kettering Cancer Center, New York City, NY, discusses the applications of machine learning in liquid biopsy. Machine learning has the potential to detect ctDNA in low quantities, which could make it highly beneficial in situations such as early detection of disease and assessing minimal residual disease after surgery. This interview took place at the International Society of Liquid Biopsy (ISLB) 2022 congress in Miami, FL.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.